Walgreens Boots Alliance (WBA) Scheduled to Post Quarterly Earnings on Thursday

Walgreens Boots Alliance (NASDAQ:WBA) is scheduled to be announcing its earnings results before the market opens on Thursday, June 27th. Analysts expect the company to announce earnings of $0.68 per share for the quarter. Walgreens Boots Alliance has set its FY24 guidance at $3.20-3.35 EPS and its FY 2024 guidance at 3.200-3.350 EPS.Individual interested in registering for the company’s earnings conference call can do so using this link.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings results on Thursday, March 28th. The pharmacy operator reported $1.20 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.82 by $0.38. Walgreens Boots Alliance had a negative net margin of 4.18% and a positive return on equity of 12.11%. The firm had revenue of $37.05 billion for the quarter, compared to the consensus estimate of $35.86 billion. During the same period in the prior year, the firm posted $1.16 earnings per share. The company’s revenue for the quarter was up 6.3% on a year-over-year basis. On average, analysts expect Walgreens Boots Alliance to post $3 EPS for the current fiscal year and $3 EPS for the next fiscal year.

Walgreens Boots Alliance Trading Down 1.3 %

Shares of Walgreens Boots Alliance stock opened at $15.70 on Wednesday. The company has a current ratio of 0.66, a quick ratio of 0.32 and a debt-to-equity ratio of 0.50. The company’s 50-day moving average price is $16.76 and its 200-day moving average price is $20.36. The company has a market cap of $13.54 billion, a price-to-earnings ratio of -2.24, a PEG ratio of 0.99 and a beta of 0.78. Walgreens Boots Alliance has a 12-month low of $14.62 and a 12-month high of $31.88.

Walgreens Boots Alliance Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, June 12th. Investors of record on Tuesday, May 21st were given a $0.25 dividend. This represents a $1.00 annualized dividend and a dividend yield of 6.37%. The ex-dividend date was Monday, May 20th. Walgreens Boots Alliance’s dividend payout ratio (DPR) is -14.29%.

Wall Street Analyst Weigh In

A number of brokerages have commented on WBA. Raymond James reiterated a “market perform” rating on shares of Walgreens Boots Alliance in a research report on Tuesday, March 26th. Deutsche Bank Aktiengesellschaft cut their target price on shares of Walgreens Boots Alliance from $23.00 to $22.00 and set a “hold” rating on the stock in a report on Wednesday, April 3rd. UBS Group cut their target price on shares of Walgreens Boots Alliance from $22.00 to $17.00 and set a “neutral” rating on the stock in a report on Monday. Morgan Stanley cut their target price on shares of Walgreens Boots Alliance from $16.00 to $13.00 and set an “underweight” rating on the stock in a report on Friday, May 31st. Finally, Bank of America cut their target price on shares of Walgreens Boots Alliance from $23.00 to $22.00 and set an “underperform” rating on the stock in a report on Tuesday, March 26th. Four equities research analysts have rated the stock with a sell rating, eleven have issued a hold rating and two have given a buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $23.07.

Insider Buying and Selling at Walgreens Boots Alliance

In other news, CFO Manmohan Mahajan purchased 6,000 shares of the business’s stock in a transaction on Tuesday, April 2nd. The stock was acquired at an average cost of $19.38 per share, for a total transaction of $116,280.00. Following the purchase, the chief financial officer now directly owns 166,969 shares in the company, valued at approximately $3,235,859.22. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. In related news, Director Inderpal S. Bhandari acquired 3,000 shares of the stock in a transaction dated Thursday, April 11th. The shares were purchased at an average cost of $18.05 per share, with a total value of $54,150.00. Following the transaction, the director now directly owns 3,000 shares in the company, valued at $54,150. The acquisition was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CFO Manmohan Mahajan acquired 6,000 shares of the stock in a transaction dated Tuesday, April 2nd. The shares were bought at an average cost of $19.38 per share, for a total transaction of $116,280.00. Following the completion of the transaction, the chief financial officer now owns 166,969 shares in the company, valued at $3,235,859.22. The disclosure for this purchase can be found here. Corporate insiders own 17.40% of the company’s stock.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.